Medincell SA (MEDCL) - Total Liabilities

Latest as of September 2025: €105.21 Million EUR ≈ $123.00 Million USD

Based on the latest financial reports, Medincell SA (MEDCL) has total liabilities worth €105.21 Million EUR (≈ $123.00 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Medincell SA growing its equity to track the company's year-over-year net asset growth rate.

Medincell SA - Total Liabilities Trend (2016–2025)

This chart illustrates how Medincell SA's total liabilities have evolved over time, based on quarterly financial data. See MEDCL cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Medincell SA Competitors by Total Liabilities

The table below lists competitors of Medincell SA ranked by their total liabilities.

Company	Country	Total Liabilities
Sino Medical Sciences Technology In SHG:688108	China	CN¥263.39 Million
Everlight Electronics Co Ltd TW:2393	Taiwan	NT$9.55 Billion
Scandi Standard publ AB ST:SCST	Sweden	Skr4.96 Billion
Zhejiang Zhengguang Industrial Co. Ltd. SHE:301092	China	CN¥228.41 Million
Genus Power Infrastructures Limited NSE:GENUSPOWER	India	Rs35.49 Billion
Supalai Public Company Limited BK:SPALI	Thailand	฿44.50 Billion
AMG Advanced Metallurgical Group NV AS:AMG	Netherlands	€1.63 Billion
Medartis Holding AG SW:MED	Switzerland	CHF284.05 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Medincell SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Medincell SA.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-3.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medincell SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medincell SA (2016–2025)

The table below shows the annual total liabilities of Medincell SA from 2016 to 2025.

Year	Total Liabilities	Change
2025-03-31	€106.82 Million ≈ $124.88 Million	+37.35%
2024-03-31	€77.77 Million ≈ $90.92 Million	+8.57%
2023-03-31	€71.63 Million ≈ $83.75 Million	+24.20%
2022-03-31	€57.67 Million ≈ $67.43 Million	+5.46%
2021-03-31	€54.69 Million ≈ $63.94 Million	+26.41%
2020-03-31	€43.27 Million ≈ $50.58 Million	+36.31%
2019-03-31	€31.74 Million ≈ $37.11 Million	-14.45%
2018-03-31	€37.10 Million ≈ $43.38 Million	+45.20%
2017-03-31	€25.55 Million ≈ $29.87 Million	+159.47%
2016-03-31	€9.85 Million ≈ $11.51 Million	--

About Medincell SA

PA:MEDCL France Biotechnology

Market Cap

$1.07 Billion

€912.03 Million EUR

Market Cap Rank

#9036 Global

#148 in France

Share Price

€25.40

Change (1 day)

+1.20%

52-Week Range

€15.70 - €38.46

All Time High

€38.46